Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemical kinetic mechanistic models to investigate cancer biology and impact cancer medicine.

Physical biology - 1 Apr 2013

Stites Edward C

Abstract excerpt

Traditional experimental biology has provided a mechanistic understanding of cancer in which the malignancy develops through the acquisition of mutations that disrupt cellular processes. Several drugs developed to target such mutations have now demonstrated clinical value. These advances are unequivocal testaments to the value of traditional cellular and molecular biology. However, several features of cancer may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computer Simulation
Share to Models, Biological
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Signal Transduction

Share to Systems Biology

Source

Identifiers

PMID: 23406820
DOI: 10.1088/1478-3975/10/2/026004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemical kinetic mechanistic models to investigate cancer biology and impact cancer medicine.PMID 23406820Read ↗

Mechanistic modeling to investigate signaling by oncogenic Ras mutants.Semantic proximity Read ↗

Future of personalized medicine in oncology: a systems biology approach.Semantic proximity Read ↗

What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity.Semantic proximity Read ↗

A quantitative systems pharmacology analysis of KRAS G12C covalent inhibitorsSemantic proximity Read ↗

Modeling Signaling Networks to Advance New Cancer Therapies.Semantic proximity Read ↗

Mechanistic systems modeling to guide drug discovery and development.Semantic proximity Read ↗

Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia.Semantic proximity Read ↗

Mathematical Modeling to Study KRAS Mutant-Specific Responses to Pathway Inhibition.Semantic proximity Read ↗

A probabilistic approach to identify putative drug targets in biochemical networks.Semantic proximity Read ↗

Possibility of correlating mutational profile of cancer with drugs suitable for treatmentSemantic proximity Read ↗

Rapid Discrimination Among Putative Mechanistic Models of Biochemical Systems.Semantic proximity Read ↗

Mathematical investigation of how oncogenic ras mutants promote ras signaling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.